{"nct_id":"NCT04704921","title":"Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2020-12-29","start_date_type":"ACTUAL","primary_completion_date":"2026-12","primary_completion_date_type":"ESTIMATED","completion_date":"2027-11","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["ABBV"]}